Human natural killer cells in asymptomatic human immunodeficiency virus-1 Infection

被引:0
|
作者
Hulström, AL
Hejdeman, B
Leandersson, AC
Bratt, G
Carbone, E
Wahren, B [1 ]
机构
[1] Swedish Inst Infect Dis Control, Dept Virol, Microbiol & Tumorbiol Ctr, SE-17182 Solna, Sweden
[2] Karolinska Inst, South Hosp, Dept Venereol, Stockholm, Sweden
[3] Swedish Inst Infect Dis Control, Microbiol & Tumorbiol Ctr, Stockholm, Sweden
关键词
NK cells; HIV-1; DNA vaccine;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objectives: We evaluated whether DNA immunization with HIV-1 regulatory genes change natural killer (NK) effector cell activity. NK cells are the most important cells for the immediate host defense against virus-infected and tumor cells. We analyzed the NK activities of HIV-1-infected individuals against K562 cells (the classical assay) as well as against a CD4+ cell line with and without HIV-7 infection. CD4+ T lymphocytes are the main target cells for HIV-7 infection in vivo. Various proportions of the CD4+ T lymphocyte population carry the HIV-1 genome, produce virus and contribute to the systemic spread of HIV-1. Methods: CD4+ cell lines were established through HTLV-1 transformation which made the cells susceptible to NK lysis, NK activity was then tested in a Cr-51 release assay. Results: NK cells of asymptomatic HIV-infected individuals mediated considerable lytic activity against K562 cells as well as against the uninfected and HIV-1-infected CD4+ cell line, and so did the NK cells of HIV-1-infected patients on highly active antiretroviral treatment. Conclusion: DNA immunization with HIV-7-regulatory genes did not significantly change the NK effector cell activity. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:294 / 301
页数:8
相关论文
共 50 条
  • [1] Natural Killer Cells in Human Immunodeficiency Virus-1 Infection: Spotlight on the Impact of Human Cytomegalovirus
    Peppa, Dimitra
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [2] Natural killer T cells are targets for human immunodeficiency virus infection
    Crowe, NY
    Godfrey, DI
    Baxter, AG
    IMMUNOLOGY, 2003, 108 (01) : 1 - 2
  • [3] THROMBOCYTOPENIA AND HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
    WALSH, CM
    KARPATKIN, S
    SEMINARS IN ONCOLOGY, 1990, 17 (03) : 367 - 374
  • [4] Surgery and human immunodeficiency virus-1 infection
    Wastell, C
    Corless, D
    Keeling, N
    AMERICAN JOURNAL OF SURGERY, 1996, 172 (01): : 89 - 92
  • [5] NEUROPATHOLOGY OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
    HENIN, D
    HAUW, JJ
    PRESSE MEDICALE, 1988, 17 (40): : 2129 - 2133
  • [6] NATURAL-KILLER CYTOTOXICITY DIRECTED AGAINST CELLS INFECTED WITH HETEROLOGOUS HUMAN IMMUNODEFICIENCY VIRUS-1
    RAMSEY, KM
    STANTON, GJ
    CLOYD, MW
    CLINICAL RESEARCH, 1990, 38 (02): : A560 - A560
  • [7] NATURAL-KILLER CYTOTOXICITY DIRECTED AGAINST CELLS INFECTED WITH HETEROLOGOUS HUMAN IMMUNODEFICIENCY VIRUS-1
    RAMSEY, KM
    STANTON, GJ
    CLOYD, MW
    CLINICAL RESEARCH, 1990, 38 (01): : A14 - A14
  • [8] Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection
    Stern, RA
    Silva, SG
    Chaisson, N
    Evans, DL
    ARCHIVES OF NEUROLOGY, 1996, 53 (02) : 148 - 153
  • [9] NATURAL-HISTORY OF VERTICALLY ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
    LIDINJANSSON, G
    LJUNG, R
    CHRISTENSSON, B
    MELICA, F
    CIRILLO, C
    BARIGIONE, G
    BELLOMO, M
    CAOCCI, F
    SPRECHER, S
    CLUMECK, N
    GIMENEZ, E
    SIERRA, C
    VINOLAS, M
    LOPEZ, MA
    PEDIATRICS, 1994, 94 (06) : 815 - 819
  • [10] EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS-1 IN HUMAN COLONIC CELLS
    KAGNOFF, MF
    OMARY, MB
    DEGRANDPRE, LY
    ROEBUCK, KA
    RICHMAN, DD
    BRENNER, DA
    IMMUNOLOGIC RESEARCH, 1991, 10 (3-4) : 452 - 455